Department of Geratology, Shanxi Cancer Hospital, Taiyuan, Shanxi, China.
Department of Chest Surgery, Minhang Hospital, Fudan University, Shanghai, China.
J Surg Res. 2020 Jun;250:216-223. doi: 10.1016/j.jss.2019.12.053. Epub 2020 Feb 21.
Krüppel-like factor 7 (KLF7), which belongs to the KLF family of zinc finger transcription factors, plays a critical role in regulating gene expression. It was reported that KLF7 overexpression was closely related to the progression of gastric cancer. However, the role of KLF7 in lung adenocarcinoma (LAC) has not been elucidated. The aim of our study is to investigate the expression pattern of KLF7 and explore whether the KLF7 expression is correlated with unfavorable clinical outcome of patients with LAC.
The protein and mRNA levels of KLF7 were examined in LAC tissues by using immunohistochemistry staining and quantitative reverse transcription polymerase chain reaction, respectively. The prognostic role of KLF7 in patients with LAC was assessed using univariate and multivariate analyses. Clinical outcomes were evaluated by Kaplan-Meier analysis and logrank test. The effects of KLF7 on lung cancer cells were investigated through cellular experiments.
KLF7 expression was elevated in LAC tissues compared with adjacent normal tissues. High protein level of KLF7 was correlated with larger tumor size, positive lymph node metastasis, and advanced TNM stage. Moreover, patients with LAC with higher expression level of KLF7 had poorer overall survival, and KLF7 was identified as an unfavorable independent prognosis factor. Knockdown of KLF7 can suppress the proliferation and invasion abilities of cancer cells.
Our studies revealed that high KLF7 expression level was significantly associated with the poorer clinical outcomes of patients with LAC, indicating the potential role of KLF7 as a novel prognostic biomarker and therapeutic target.
Krüppel 样因子 7(KLF7)属于锌指转录因子家族,在调节基因表达中发挥着关键作用。有报道称,KLF7 过表达与胃癌的进展密切相关。然而,KLF7 在肺腺癌(LAC)中的作用尚未阐明。本研究旨在探讨 KLF7 的表达模式,并研究 KLF7 的表达是否与 LAC 患者的不良临床结局相关。
采用免疫组织化学染色和实时定量逆转录聚合酶链反应分别检测 LAC 组织中 KLF7 的蛋白和 mRNA 水平。采用单因素和多因素分析评估 KLF7 对 LAC 患者预后的作用。采用 Kaplan-Meier 分析和 logrank 检验评估临床结局。通过细胞实验研究 KLF7 对肺癌细胞的影响。
与相邻正常组织相比,LAC 组织中 KLF7 的表达升高。KLF7 蛋白水平高与肿瘤较大、淋巴结转移阳性和 TNM 分期较晚有关。此外,KLF7 表达水平较高的 LAC 患者总生存率较低,KLF7 是不良的独立预后因素。敲低 KLF7 可抑制癌细胞的增殖和侵袭能力。
本研究表明,KLF7 高表达水平与 LAC 患者的临床结局较差显著相关,提示 KLF7 可能作为一种新的预后生物标志物和治疗靶点。